AcquiredStartups
Biggest in Johnson & Johnson
Acquirer · Corporate

Johnson & Johnson

1Exits tracked$2.2bnDisclosed value$2.2bnMedian price0Acquihires
Photo: Quintin Soloviev / Wikimedia Commons, CC BY 4.0
Healthtech & bio · Austin

Johnson & Johnson to buy eye-drug startup Ollin Biosciences for $2.2 billion upfront

Founded in 2023, Ollin could fetch up to about $3.3 billion with milestones, while Blackstone has agreed to pay $750 million toward the Phase 3 trials of its lead drug.

Price$2.2bnRaised$430mLast stageSeries BBuyer typeCorporate
Latest in Johnson & JohnsonMore stories here soon.